Skip to main content

Labcorp Message (as of July 21, 4:00 p.m. ET)

  • All Labcorp core systems impacted by the CrowdStrike issues are currently back online.
  • Some of our patient service centers and in-office labs may be experiencing technical issues with retrieving orders.
  • We are working hard to resolve this issue.
  • If you have a copy of your order, this will help expedite the process.
  • We appreciate your patience as we work to restore business operations.
  • Various immunization strategies based on your needs

  • Over four decades of extensive experience

  • Polyclonal and monoclonal antibody services

Tool antibody reagents can be polyclonal and/or monoclonal antibodies generated using standard immunization strategies and hybridoma technologies. These antibody reagents are often used in the discovery phase of research to characterize proteins and validate targets.

At Labcorp, we devise various immunization strategies based on the nature of the antigen and the intended application to generate high-titer, high-affinity antibodies. Our staff’s extensive experience with tens of thousands of projects over the last four decades is at your disposable to make your discovery program a success.

Polyclonal and monoclonal antibody services

  • Various host species available
  • Variety of antibody screening modalities
  • Antibody purification and labeling options
  • Characterization of antibody product
     

Anti-peptide antibody

  • Peptide design and synthesis
  • Conjugation to carrier proteins
  • Biotinylation of peptide
     

Anti-protein antibody

  • Various antigen formats (soluble, gel slices, inclusion bodies, fusion proteins, etc.)
  • Purification strategies to improve specificity
     

Post-transitional modification (PTM) antibodies

  • Phosphorylation
  • Methylation
  • Acetylation
  • Other modifications
     

Anti-hapten antibody

  • Unique small, organic molecules (modified cholesterol, polysaccharides)

Learn more about our polyclonal and monoclonal antibody services .
 

Let's start a conversation